Market Cap 19.90B
Revenue (ttm) 2.07B
Net Income (ttm) 418.30M
EPS (ttm) N/A
PE Ratio 60.74
Forward PE 45.02
Profit Margin 20.19%
Debt to Equity Ratio 0.73
Volume 664,500
Avg Vol 724,702
Day's Range N/A - N/A
Shares Out 70.35M
Stochastic %K 46%
Beta 1.40
Analysts Strong Sell
Price Target $376.42

Company Profile

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; and Omnipod DASH insulin management system...

Industry: Medical Devices
Sector: Healthcare
Phone: 978 600 7000
Address:
100 Nagog Park, Acton, United States
BillionerOfKing
BillionerOfKing Jan. 14 at 6:33 PM
$PODD Current Stock Price: $282.99
0 · Reply
JInvestTrade
JInvestTrade Jan. 13 at 10:03 PM
$SENS , $DXCM , $TNDM , $PODD , $MDT https://www.linkedin.com/posts/senseonics-inc_senseonics-announces-first-commercial-patients-activity-7416833660223647744-CxCW?utm_medium=ios_app&rcm=ACoAACZifW0B2JqOqHkWvrhyPzzcI0ENdA47TYM&utm_source=social_share_send&utm_campaign=copy_link
0 · Reply
JohnSalvage771
JohnSalvage771 Jan. 12 at 2:54 PM
$CTRA $PODD $EXPD Nicely balanced view
0 · Reply
nOObtownfinancial
nOObtownfinancial Jan. 9 at 2:18 PM
$MODD I had to ask myself. Why is this moving? Targeted Launch date: Q1 2026 Q1 2026 is now (Jan/Feb/Mar) Main Squeeze for me is the pudding $TNDM PIVOT Pump vs the trial MODD1 Pump: -Tubeless Design: MODD1 used a short tube; Pivot is a 100% tubeless patch pump.Looking at you $PODD -Connectivity: MODD1 had limited app/monitoring functionality. Pivot adds full iOS/Android connectivity. The PIVOT still does not need a phone or external device. Standard HUGE+++ over arguably its only competitor. -Durability: 90-day reusable pump life remains the same, w/2-3 day(300 Unit) reservoir. Lost the small tube infusion site. -Gamified Training: No more slide decks in the doctors office. Pivot uses interactive, gamified training to get patients up and running in minutes. Only question I have left is, How do I sign up? I am not delusional about my $22 target price. It is more in the neighborhood of $7 to $10. But $22 is not out of the picture. I am nervous for the value trap. As a consumer, LFG📈🚀
2 · Reply
JInvestTrade
JInvestTrade Jan. 9 at 4:13 AM
More accurate than $DXCM and $ABBV and it works for 1 year. $SENS, $PODD, $TNDM. https://www.linkedin.com/posts/gingervieira_you-ask-hows-the-accuracy-on-the-eversense-activity-7413296265230458880-6FRr?utm_medium=ios_app&rcm=ACoAACZifW0B2JqOqHkWvrhyPzzcI0ENdA47TYM&utm_source=social_share_send&utm_campaign=share_via
2 · Reply
JInvestTrade
JInvestTrade Jan. 9 at 4:08 AM
$SENS Picking up momentum. $SENS, $DXCM, $ABVI, $TNDM, $PODD https://www.linkedin.com/posts/amy-morris-2861662b_what-a-year-2025-11-eversense-patients-activity-7409366551700828160-wCAr?utm_medium=ios_app&rcm=ACoAACZifW0B2JqOqHkWvrhyPzzcI0ENdA47TYM&utm_source=social_share_send&utm_campaign=share_via
0 · Reply
SPYmyQQQ
SPYmyQQQ Jan. 8 at 1:34 PM
🎯 Target Hit 🏁 📨 From Dec 12, 2025 🏛️ $PODD 💵 Entry: $296.0600 ✅ Exit: $303.0470 💰 P/L: +2.36% 👉 FREE TRIAL! spymyqqq/join/
0 · Reply
JInvestTrade
JInvestTrade Jan. 7 at 11:40 PM
$SENS, $DXCM, $PODD, $TNDM, $ABBV https://www.linkedin.com/posts/eversense-cgm_why-calibrate-eversense-365-activity-7414708763233927169-ya3A?utm_medium=ios_app&rcm=ACoAACZifW0B2JqOqHkWvrhyPzzcI0ENdA47TYM&utm_source=social_share_send&utm_campaign=share_via
0 · Reply
Stringy51
Stringy51 Jan. 7 at 5:02 AM
$PODD several good articles and now momentum back to hopefully 340-350?
0 · Reply
bulltrades1234
bulltrades1234 Jan. 2 at 6:15 PM
$PODD podd just keeps on dumping
0 · Reply
Latest News on PODD
Insulet Corporation (PODD) Analyst/Investor Day Transcript

Nov 20, 2025, 8:13 PM EST - 2 months ago

Insulet Corporation (PODD) Analyst/Investor Day Transcript


PODD Vs. Intuitive Surgical: This Underdog Might Just Win

Nov 12, 2025, 2:15 PM EST - 2 months ago

PODD Vs. Intuitive Surgical: This Underdog Might Just Win

ISRG


Insulet Corporation (PODD) Q3 2025 Earnings Call Transcript

Nov 6, 2025, 12:46 PM EST - 2 months ago

Insulet Corporation (PODD) Q3 2025 Earnings Call Transcript


Insulet Reports Third Quarter 2025 Results

Nov 6, 2025, 6:30 AM EST - 2 months ago

Insulet Reports Third Quarter 2025 Results


Final Trades: Insulet Corp, Uber and Apollo Global

Nov 4, 2025, 1:20 PM EST - 2 months ago

Final Trades: Insulet Corp, Uber and Apollo Global

APO UBER


Insulet to Host Investor Day on November 20, 2025

Oct 10, 2025, 7:00 AM EDT - 3 months ago

Insulet to Host Investor Day on November 20, 2025


Insulet Announces CFO Transition

Sep 16, 2025, 7:00 AM EDT - 4 months ago

Insulet Announces CFO Transition


Insulet Elevates Eric Benjamin to Chief Operating Officer

Aug 25, 2025, 5:00 PM EDT - 5 months ago

Insulet Elevates Eric Benjamin to Chief Operating Officer


Insulet to Participate in Upcoming Investor Conferences

Aug 19, 2025, 6:00 AM EDT - 5 months ago

Insulet to Participate in Upcoming Investor Conferences


Insulet Corporation (PODD) Q2 2025 Earnings Call Transcript

Aug 7, 2025, 11:14 AM EDT - 5 months ago

Insulet Corporation (PODD) Q2 2025 Earnings Call Transcript


Outlier Money Flows Lift Insulet

May 14, 2025, 7:20 AM EDT - 8 months ago

Outlier Money Flows Lift Insulet


Insulet Announces Publication of 2024 Sustainability Report

May 13, 2025, 6:00 AM EDT - 8 months ago

Insulet Announces Publication of 2024 Sustainability Report


Insulet Is the Top S&P 500 Performer Today. Here's Why.

May 9, 2025, 10:11 AM EDT - 9 months ago

Insulet Is the Top S&P 500 Performer Today. Here's Why.


Insulet Corporation (PODD) Q1 2025 Earnings Call Transcript

May 8, 2025, 10:35 PM EDT - 9 months ago

Insulet Corporation (PODD) Q1 2025 Earnings Call Transcript


BillionerOfKing
BillionerOfKing Jan. 14 at 6:33 PM
$PODD Current Stock Price: $282.99
0 · Reply
JInvestTrade
JInvestTrade Jan. 13 at 10:03 PM
$SENS , $DXCM , $TNDM , $PODD , $MDT https://www.linkedin.com/posts/senseonics-inc_senseonics-announces-first-commercial-patients-activity-7416833660223647744-CxCW?utm_medium=ios_app&rcm=ACoAACZifW0B2JqOqHkWvrhyPzzcI0ENdA47TYM&utm_source=social_share_send&utm_campaign=copy_link
0 · Reply
JohnSalvage771
JohnSalvage771 Jan. 12 at 2:54 PM
$CTRA $PODD $EXPD Nicely balanced view
0 · Reply
nOObtownfinancial
nOObtownfinancial Jan. 9 at 2:18 PM
$MODD I had to ask myself. Why is this moving? Targeted Launch date: Q1 2026 Q1 2026 is now (Jan/Feb/Mar) Main Squeeze for me is the pudding $TNDM PIVOT Pump vs the trial MODD1 Pump: -Tubeless Design: MODD1 used a short tube; Pivot is a 100% tubeless patch pump.Looking at you $PODD -Connectivity: MODD1 had limited app/monitoring functionality. Pivot adds full iOS/Android connectivity. The PIVOT still does not need a phone or external device. Standard HUGE+++ over arguably its only competitor. -Durability: 90-day reusable pump life remains the same, w/2-3 day(300 Unit) reservoir. Lost the small tube infusion site. -Gamified Training: No more slide decks in the doctors office. Pivot uses interactive, gamified training to get patients up and running in minutes. Only question I have left is, How do I sign up? I am not delusional about my $22 target price. It is more in the neighborhood of $7 to $10. But $22 is not out of the picture. I am nervous for the value trap. As a consumer, LFG📈🚀
2 · Reply
JInvestTrade
JInvestTrade Jan. 9 at 4:13 AM
More accurate than $DXCM and $ABBV and it works for 1 year. $SENS, $PODD, $TNDM. https://www.linkedin.com/posts/gingervieira_you-ask-hows-the-accuracy-on-the-eversense-activity-7413296265230458880-6FRr?utm_medium=ios_app&rcm=ACoAACZifW0B2JqOqHkWvrhyPzzcI0ENdA47TYM&utm_source=social_share_send&utm_campaign=share_via
2 · Reply
JInvestTrade
JInvestTrade Jan. 9 at 4:08 AM
$SENS Picking up momentum. $SENS, $DXCM, $ABVI, $TNDM, $PODD https://www.linkedin.com/posts/amy-morris-2861662b_what-a-year-2025-11-eversense-patients-activity-7409366551700828160-wCAr?utm_medium=ios_app&rcm=ACoAACZifW0B2JqOqHkWvrhyPzzcI0ENdA47TYM&utm_source=social_share_send&utm_campaign=share_via
0 · Reply
SPYmyQQQ
SPYmyQQQ Jan. 8 at 1:34 PM
🎯 Target Hit 🏁 📨 From Dec 12, 2025 🏛️ $PODD 💵 Entry: $296.0600 ✅ Exit: $303.0470 💰 P/L: +2.36% 👉 FREE TRIAL! spymyqqq/join/
0 · Reply
JInvestTrade
JInvestTrade Jan. 7 at 11:40 PM
$SENS, $DXCM, $PODD, $TNDM, $ABBV https://www.linkedin.com/posts/eversense-cgm_why-calibrate-eversense-365-activity-7414708763233927169-ya3A?utm_medium=ios_app&rcm=ACoAACZifW0B2JqOqHkWvrhyPzzcI0ENdA47TYM&utm_source=social_share_send&utm_campaign=share_via
0 · Reply
Stringy51
Stringy51 Jan. 7 at 5:02 AM
$PODD several good articles and now momentum back to hopefully 340-350?
0 · Reply
bulltrades1234
bulltrades1234 Jan. 2 at 6:15 PM
$PODD podd just keeps on dumping
0 · Reply
ZacksResearch
ZacksResearch Jan. 2 at 12:35 PM
$PODD up 10.6% in a year, but is it all about Omnipod? 🤔 Omnipod 5 is driving growth with FDA-cleared innovation and international expansion, yet macroeconomic uncertainties and reliance on a single product raise red flags. Discover if Insulet’s momentum can continue 👉 https://www.zacks.com/stock/news/2811193/is-it-the-right-time-to-add-insulet-stock-to-your-portfolio?cid=sm-stocktwits-2-2811193-body-27076&ADID=SYND_STOCKTWITS_TWEET_2_2811193_BODY_27076
0 · Reply
ZacksResearch
ZacksResearch Jan. 2 at 11:35 AM
$PODD gaining serious momentum — is the market finally catching on? 🚀 Omnipod 5 adoption is accelerating, margins are scaling, and earnings estimates are moving higher — a powerful combo, even as macro and concentration risks stay in the picture. ⚠️ Full breakdown of the upside and the risks here 👉 https://www.zacks.com/stock/news/2811193/is-it-the-right-time-to-add-insulet-stock-to-your-portfolio?cid=sm-stocktwits-2-2811193-teaser-27075&ADID=SYND_STOCKTWITS_TWEET_2_2811193_TEASER_27075
0 · Reply
BillionerOfKing
BillionerOfKing Dec. 24 at 10:03 AM
$PODD Current Stock Price: $285.45 Contracts to trade: $290 PODD Jan 16 2026 Call Entry: $12.15 Exit: $17.62 ROI: 45% Hold ~27 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
BillionerOfKing
BillionerOfKing Dec. 19 at 9:10 AM
$PODD Current Stock Price: $292.83 Contracts to trade: $290 PODD Dec 19 2025 Call Entry: $5.13 Exit: $7.82 ROI: 52% Hold ~26 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
JarvisFlow
JarvisFlow Dec. 18 at 2:28 PM
Truist Securities has updated their rating for Insulet ( $PODD ) to Buy with a price target of 390.
0 · Reply
JarvisFlow
JarvisFlow Dec. 17 at 8:06 PM
Canaccord Genuity has adjusted their stance on Insulet ( $PODD ), setting the rating to Buy with a target price of 432 → 450.
1 · Reply
JarvisFlow
JarvisFlow Dec. 16 at 1:58 PM
Evercore ISI Group has updated their rating for Insulet ( $PODD ) to Outperform with a price target of 370.
0 · Reply
JInvestTrade
JInvestTrade Dec. 16 at 1:45 AM
$SENS $DXCM $ABT $PODD $TNDM https://www.linkedin.com/posts/eversense-cgm_eversense365-eversensecgm-diabetes-activity-7406347355777630210-2aXK?utm_medium=ios_app&rcm=ACoAACZifW0B2JqOqHkWvrhyPzzcI0ENdA47TYM&utm_source=social_share_send&utm_campaign=share_via
0 · Reply
ZacksResearch
ZacksResearch Dec. 15 at 12:58 PM
MedTech stocks to watch in 2026: $ISRG, $PODD, $BSX, $IDXX 🚀 🦾 ISRG: Da Vinci systems drive expected 14.3% revenue growth in 2026, Zacks Rank #1 📈 PODD: Omnipod 5 expansion fuels 19.8% revenue boost, Zacks Rank #2 💉 BSX: WATCHMAN & FARAPULSE tech gain traction, Zacks Rank #2 🐾 IDXX: Companion Animal diagnostics thrive, Zacks Rank #2 Discover why these could outperform 👉 https://www.zacks.com/stock/news/2804170/4-medical-device-stocks-to-buy-for-healthy-returns-in-2026?cid=sm-stocktwits-2-2804170-body-24744&ADID=SYND_STOCKTWITS_TWEET_2_2804170_BODY_24744
0 · Reply
ZacksResearch
ZacksResearch Dec. 15 at 11:58 AM
Medtech’s next growth wave is taking shape — and these names are leading it 🚀 $ISRG, $PODD, $BSX and $IDXX are highlighted as leaders in medtech innovation, leveraging AI, robotics, and diagnostics as key growth drivers heading into 2026. See how each company is positioned to benefit from these technologies 👉 https://www.zacks.com/stock/news/2804170/4-medical-device-stocks-to-buy-for-healthy-returns-in-2026?cid=sm-stocktwits-2-2804170-teaser-24735&ADID=SYND_STOCKTWITS_TWEET_2_2804170_TEASER_24735
0 · Reply
melinavaughn
melinavaughn Dec. 12 at 5:26 PM
$PODD Mainz Biomed is the exact tape that can shock people later, ~310k shares short (reported) against a micro float setup, any sustained bid can force ugly covering
0 · Reply
TrevPhil13
TrevPhil13 Dec. 12 at 1:49 PM
$PODD They have updated algorithm coming soon and libre 3 integration. They don't have any real competitors at the moment. This should go only up from here.
0 · Reply